Literature DB >> 16297729

Future directions in treatment of joint disease in horses.

David D Frisbie1.   

Abstract

Osteoarthritis is one of the most economically important diseases facing equine practitioners. The loss of use associated with joint disease is a leading problem in the equine industry. Although osteoarthritis in all species is believed to be a multifactorial disease that is not well understood, significant advances are being made. This article presents areas of research that are relatively well developed but have not made it to commercialization or routine clinical practice and looks at new applications being investigated for peo-ple that may have an equine application.

Entities:  

Mesh:

Year:  2005        PMID: 16297729     DOI: 10.1016/j.cveq.2005.07.001

Source DB:  PubMed          Journal:  Vet Clin North Am Equine Pract        ISSN: 0749-0739            Impact factor:   1.792


  7 in total

1.  Combined use of platelet rich plasma & micro-fat in sport and race horses with degenerative joint disease: preliminary clinical study in eight horses.

Authors:  Fabrizio Bembo; Julia Eraud; Cecile Philandrianos; Baptiste Bertrand; Alain Silvestre; Julie Veran; Florence Sabatier; Guy Magalon; Jeremy Magalon
Journal:  Muscles Ligaments Tendons J       Date:  2016-09-17

2.  Are Stem Cells Derived from Synovium and Fat Pad Able to Treat Induced Knee Osteoarthritis in Rats?

Authors:  Reza Zare; Nader Tanideh; Behrooz Nikahval; Maryam Sadat Mirtalebi; Nasrollah Ahmadi; Shahrokh Zarea; Omid Koohi Hosseinabadi; Rohan Bhimani; Soheil Ashkani-Esfahani
Journal:  Int J Rheumatol       Date:  2020-07-13

3.  Isolation, growth and differentiation of equine mesenchymal stem cells: effect of donor, source, amount of tissue and supplementation with basic fibroblast growth factor.

Authors:  Silvia Colleoni; Emanuela Bottani; Irene Tessaro; Gaetano Mari; Barbara Merlo; Noemi Romagnoli; Alessandro Spadari; Cesare Galli; Giovanna Lazzari
Journal:  Vet Res Commun       Date:  2009-12       Impact factor: 2.459

4.  Phenotypic and immunomodulatory properties of equine cord blood-derived mesenchymal stromal cells.

Authors:  Laurence Tessier; Dorothee Bienzle; Lynn B Williams; Thomas G Koch
Journal:  PLoS One       Date:  2015-04-22       Impact factor: 3.240

5.  Intra-Articular Injection of 2 Different Dosages of Autologous and Allogeneic Bone Marrow- and Umbilical Cord-Derived Mesenchymal Stem Cells Triggers a Variable Inflammatory Response of the Fetlock Joint on 12 Sound Experimental Horses.

Authors:  Lélia Bertoni; Thomas Branly; Sandrine Jacquet; Mélanie Desancé; Loïc Desquilbet; Pascaline Rivory; Daniel-Jean Hartmann; Jean-Marie Denoix; Fabrice Audigié; Philippe Galéra; Magali Demoor
Journal:  Stem Cells Int       Date:  2019-05-02       Impact factor: 5.443

6.  Isolation of mesenchymal stem cells from equine umbilical cord blood.

Authors:  Thomas G Koch; Tammy Heerkens; Preben D Thomsen; Dean H Betts
Journal:  BMC Biotechnol       Date:  2007-05-30       Impact factor: 2.563

7.  Regenerative therapies for equine degenerative joint disease: a preliminary study.

Authors:  Sarah Broeckx; Marieke Zimmerman; Sara Crocetti; Marc Suls; Tom Mariën; Stephen J Ferguson; Koen Chiers; Luc Duchateau; Alfredo Franco-Obregón; Karin Wuertz; Jan H Spaas
Journal:  PLoS One       Date:  2014-01-20       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.